Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. At-004
2. Chembl4435280
3. 2099680-36-9
4. Orb2565655
5. Schembl18920957
6. Schembl18920958
7. Schembl20212843
8. Schembl21179587
9. Glxc-22198
10. Bdbm50514545
11. Hy-156993
12. Cs-0905782
13. 1-(1-((1s,4s)-4-isopropylcyclohexyl)piperidin-4-yl)-1h-indole
| Molecular Weight | 324.5 g/mol |
|---|---|
| Molecular Formula | C22H32N2 |
| XLogP3 | 5.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 3 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 8.2 |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 391 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
52
PharmaCompass offers a list of NOP agonist-2 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right NOP agonist-2 manufacturer or NOP agonist-2 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred NOP agonist-2 manufacturer or NOP agonist-2 supplier.
A NOP agonist-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NOP agonist-2, including repackagers and relabelers. The FDA regulates NOP agonist-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NOP agonist-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NOP agonist-2 supplier is an individual or a company that provides NOP agonist-2 active pharmaceutical ingredient (API) or NOP agonist-2 finished formulations upon request. The NOP agonist-2 suppliers may include NOP agonist-2 API manufacturers, exporters, distributors and traders.
NOP agonist-2 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NOP agonist-2 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right NOP agonist-2 GMP manufacturer or NOP agonist-2 GMP API supplier for your needs.
A NOP agonist-2 CoA (Certificate of Analysis) is a formal document that attests to NOP agonist-2's compliance with NOP agonist-2 specifications and serves as a tool for batch-level quality control.
NOP agonist-2 CoA mostly includes findings from lab analyses of a specific batch. For each NOP agonist-2 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NOP agonist-2 may be tested according to a variety of international standards, such as European Pharmacopoeia (NOP agonist-2 EP), NOP agonist-2 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NOP agonist-2 USP).
